ZIOC latest update: 6th May RNS and Presentation...9 May 2026 21:37
ZIOC hasn't tweeted anything, but the Presentation is now up on the website ....and Tamesis has published a research note (also 6th May), viewable on Researchtree.
Key takeaways from the RNS:
(1) The non-production of updated costings promised 6th Jan for latest end Feb has appeared (4 months later), explained by .." in January 2026 ..... ZIOC still did not possess updated estimates for the newly designed DRI process plant. Today, as the final step of the Programme, the DRI process plant results are completed and incorporated into an updated financial model and economic evaluation....".
This non-availability would have been known at the time, no?
(2) Somewhat confusingly, to me at least, the RNS then says re 'updated project economics' that these 'are now updated and accurate as of end December 2025'.
So, are the April 26 adjustments factored in, Y or N?
followed by
(3).." Upon analysis of the single-pipeline option, announced in January 2026, the April 2026 Case RETAINS the two-stage pipeline design basis, involving the construction of a 12Mtpa capacity pipeline for Stage One, and an additional 18Mtpa capacity pipeline for the Stage Two expansion to 30Mtpa total production capacity...'
So the commercially, logistically, legally and environmentally rational option has been discarded for present purposes.
However,
.."the single 30Mtpa pipeline system is potentially advantageous for large strategic investors seeking to ramp up production capacity faster to 30Mtpa, as it eliminates the need for a second pipeline installation, thereby simplifying permitting processes, reducing environmental and community impacts, and significantly reducing financing needs in the second phase of expansion..."
Mixed messaging? One version for the PI's (downplaying the economic case?) , another for 'strategics' ?
(4) 2026 and 2027 Work Programme and Path to FID
Key milestones include:
· Updated mineral resource and reserve modelling and Bulk sampling and pilot-scale metallurgical testing (this seem to be new?);
and
· Updated financial modelling and project economics (wasn't this already done?)
(5) Oh, by the way, .."transaction agreements are now targeted for completion during July 2026.... completion will be conditional upon shareholder approval AND ANY REQUIRED REGULATORY APPROVALS. A shareholder circular ..... together with a notice convening the EGM, will be published in due course .....
(6) We can speculate about the reasons for this 'can-kick', in any event thanks to this postponement everyone will have the benefit of audited results to December 2025....and formal disclosure of any relevant post balance-sheet date developments.
Re the Presentation, see what you think : without AI, it's hard to do a meaningful like-for like comparison...and how a drop from prev NPV becomes a 30% increase.
Re the Tamesis research note, for all the fine words, it's left its target price unch @ 11.2p.
HTH, GLA and ATB